...
首页> 外文期刊>Journal of Thoracic Disease >Comparison of specimen adequacy and diagnostic accuracy of a 25-gauge and 22-gauge needle in endobronchial ultrasound-guided transbronchial needle aspiration
【24h】

Comparison of specimen adequacy and diagnostic accuracy of a 25-gauge and 22-gauge needle in endobronchial ultrasound-guided transbronchial needle aspiration

机译:在内核超声引导横切针吸附中的25·仪表和22针针的标本充分性和诊断精度的比较

获取原文

摘要

Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the preferred diagnostic modality for sampling mediastinal and hilar lymph nodes (LNs). The conventional needle used for sampling is either a 21-gauge (21G) or 22-gauge (22G). A 25-gauge (25G) needle has recently been introduced with little known regarding its efficacy. Methods: A retrospective study was conducted on patients referred for EBUS-TBNA who had LNs sampled using a 25G or 22G needle. A propensity score matching analysis was performed. After matching the groups, each LN was assessed for adequacy and final diagnosis. Non-diagnostic and benign lymphoid specimens were compared with repeat biopsy findings or long-term clinical and radiological follow-up. Results: A total of 158 LNs were included. An adequate sample was obtained in 92.4% (73/79) in the 25G group and 92.4% (73/79) in the 22G group (P=1). The 25G group diagnosed benign lymphoid tissue in 82.3% (65/79), granuloma in 7.6% (6/79) and malignancy in 2.5% (2/79). Six lymph nodes in the 25G group were non-diagnostic (7.6%). The 22G group diagnosed benign lymphoid tissue in 83.5% (66/79), granuloma in 3.8% (3/79) and malignancy in 5.1% (4/79). Six lymph nodes in the 22G group were non-diagnostic (7.6%). The sensitivity, specificity, negative predictive value (NPV) and diagnostic accuracy in the 25G group was 88.9% (95% CI, 51.8–99.7%), 100% (95% CI, 92.1–100%), 97.8% (95% CI, 87.6–99.7%) and 98.2% (95% CI, 90.1–100%), respectively. The sensitivity, specificity, NPV and diagnostic accuracy in the 22G group was 77.8% (95% CI, 40–97.2%), 100% (95% CI, 86.8–100%), 92.9% (95% CI, 79.3–97.8%) and 94.3% (95% CI, 80.8–99.3%), respectively. The 25G and 22G group were comparable in diagnostic accuracy (P=0.7). Conclusions: The 25G and 22G needle achieve comparable specimen adequacy and diagnostic accuracy in EBUS-TBNA.
机译:背景:内胚层超声引导的横向针吸附(EBUS-TBNA)是用于采样纵隔和肺门淋巴结(LNS)的优选诊断方式。用于取样的传统针是21·仪表(21g)或22尺(22g)。最近介绍了25·仪表(25克)针,对其功效很少引入。方法:对使用25g或22g针刺的EBUS-TBNA提到的患者进行了回顾性研究。进行倾向得分匹配分析。在匹配组后,评估每个LN以进行充分性和最终诊断。将非诊断和良性淋巴样本与重复活组织检查结果或长期临床和放射性跟进进行了比较。结果:共用158个LNS。在25g基团中的92.4%(73/79)中获得足够的样品,在22g组中为92.4%(73/79)(p = 1)。 25g组诊断良性淋巴组织82.3%(65/79),肉芽肿为7.6%(6/79)和2.5%(2/79)的恶性肿瘤。 25g组中的六个淋巴结是非诊断(7.6%)。 22G组诊断为良性淋巴组织83.5%(66/79),肉芽肿为3.8%(3/79),恶性肿瘤为5.1%(4/79)。 22G组中的六个淋巴结是非诊断性的(7.6%)。 25g组中的敏感性,特异性,阴性预测值(NPV)和诊断准确性为88.9%(95%CI,51.8-99.7%,100%(95%CI,92.1-100%),97.8%(95% CI,87.6-99.7%)分别为98.2%(95%CI,90.1-100%)。 22g组的敏感性,特异性,NPV和诊断准确性为77.8%(95%CI,40-97.2%),100%(95%CI,86.8-100%),92.9%(95%CI,79.3-97.8 %)分别为94.3%(95%CI,80.8-99.3%)。 25G和22G组以诊断精度相当(P = 0.7)。结论:25G和22G针在EBUS-TBNA中实现了可比的标本充分性和诊断准确性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号